Search


Ovid's Jeremy Levin on advances in CNS, soticlestat, ROCK2, Washington and more
Jeremy Levin walks us through the science of Ovid's CNS-focused pipeline, gives his take on the health of the biotech.
Jan 22, 2024
Also look for unique social pages for BiotechTV U.
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
​
​Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.